BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Liver Cancer Therapeutics Market Trends and Forecast up to 2027

  Albany NY, United States: Liver cancer is a chronic, life threatening, and progressive disorder that begins in cells of liver.

  May 31, 2022

   · 

  7 min read
• Myocardial Infarction (MI) Therapeutics Market Growth Opportunity and Global Industry Analysis [2020-2030]

  The myocardial infarction therapeutics market has been expected to grow at a noticeable speed in the following years.

  May 31, 2022

   · 

  6 min read
• Vital Signs Monitoring Devices Is Set to Expand at a CAGR Of 8.4% To reach US$ 12.9 Billion By the Year 2030 - Comprehensive Research Report By FMI

  DUBAI, United Arab Emirates, Key stakeholders are increasingly investing in vital signs monitoring devices as well as the development of innovative products.

  May 31, 2022

   · 

  4 min read
• Sperm Bank Market Insights | Growth | Trends | Global Industry Analysis [2020-2030]

  The sperm bank market has been anticipated to experience various novel growth opportunities in the near future.

  May 31, 2022

   · 

  6 min read
• argenx Announces the UK MHRA has Granted Early Access to Efgartigimod for Generalized Myasthenia Gravis

  argenx SE announced that efgartigimod, the Company’s neonatal Fc receptor blocker has been awarded a positive scientific opinion by the MHRA under the EAMS.

  May 31, 2022

   · 

  5 min read
• Genetown

  Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna

  Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Takeda announced to transfer the marketing authorization in Japan for Moderna’s COVID-19 vaccine Spikevax™ from Takeda to Moderna in Japan as of August 1, 2022.

  May 31, 2022

   · 

  10 min read
• Business

  Burning Rock Reports First Quarter 2022 Financial Results

  Burning Rock Biotech Limited reported financial results for the three months ended March 31, 2022.

  May 31, 2022

   · 

  15 min read
• BioForest

  PAI Life Sciences Doses First Healthy Volunteer in Schistosomiasis Vaccine Clinical Trial

  PAI Life Sciences announced the dosing of the first healthy volunteer in a clinical trial of SchistoShield®, the company’s preventive vaccine against schistosomiasis, a major tropical disease threatening nearly 1 billion people in 79 countries with more than 260 million people currently infected.

  May 31, 2022

   · 

  5 min read
• Pharm Country

  BrainStorm Announces Presentations at June 2022 Scientific Conferences

  BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announces presentations at forthcoming ALS and MS scientific conferences in June 2022.

  May 31, 2022

   · 

  9 min read
• Drug Development

  Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis

  Eledon Pharmaceuticals, Inc. announced topline results from a Phase 2a clinical trial of tegoprubart in patients with amyotrophic lateral sclerosis.

  May 31, 2022

   · 

  9 min read